top of page

OPTION 1

Continuous estrogen (transdermal or oral) and separate cyclical progestogen
l1. Utrogestan® orall 200mg 12-14 days per month

2. Provera® (medroxyprogesterone) 10mg / day for 14 days

3. Climanor®(medroxyprogesterone) 10mg / day for 14 days

4.  MIRENA  Licensed for 4 years in the UK for progestogenic opposition but maybe for up to 5 years off-labe

 

OPTION 2

Combined transdermal estrogen and progestogen

1.Evorel Sequi® Estradiol 50mcg Norethisterone 170mcg Twice weekly

2. FemSeven Sequi® Estradiol 50mcg Levonorgestrel 10mcg Weekly

​

OPTION 3

Combined oral estrogen and progestogen

1. Femoston® 1/10 or 2/10 Estradiol 1mg or 2mg Dydrogesterone 10mg 
2. Elleste Duet Estradiol 1mg or 2mg Norethisterone 1mg Daily

3. Clinorette® Estradiol 2mg, 2mg Norethisterone 1mg Daily

4. Novofem® Estradiol 1mg Norethisterone 1mg Daily

5. Trisequens® Estradiol 1mg, 2mg, 2mg Norethisterone 1mg Daily

6. Tridestra® Estradiol valerate 2mg Medroxyprogesterone 20mg Daily

If LMP is less than one year then a sequential regime is indicated so withdrawal bleeds will  continueUNLESS a MIRENA is used

Switching to continuous regime
 

After a minimum of one year of HRT, women who wish to avoid a monthly withdrawal bleed may attempt a switch to a continuous combined HRT regimen which aims to give bleed-free HRT – this will also minimise the risk of endometrial hyperplasia. The timing of switching from

sequential to continuous combined HRT should be considered in relation to the woman’s age and the frequency of her menstrual cycles (prior to commencing HRT). Women under the age of 50 who had shorterdurations of amenorrhoea before starting HRT are likely to need to continue on sequential intake for a longer durationbefore switching to continuous combined HRT intake.

bottom of page